| MEHARRY MEDICAL COLLEGE | KING & SPALDING LLP | Q3 2026 | Budget/Appropriations, Education, Health Issues |
| VOICES OF ALZHEIMER'S, INC. | KING & SPALDING LLP | Q3 2026 | Health Issues, Government Issues |
| SENIOR CARE PHARMACY COALITION | KING & SPALDING LLP | Q3 2026 | Medicare/Medicaid |
| SECURE HEALTHCARE QUALITY ALLIANCE, INC. | KING & SPALDING LLP | Q3 2026 | Health Issues |
| POINTCLICKCARE TECHNOLOGIES, INC. | KING & SPALDING LLP | Q3 2026 | Health Issues |
| PHOTOCURE, INC. | KING & SPALDING LLP | Q3 2026 | Health Issues |
| MULTICARE HEALTH SYSTEM | KING & SPALDING LLP | Q3 2026 | Health Issues |
| MOLECULIGHT CORPORATION | KING & SPALDING LLP | Q3 2026 | Medicare/Medicaid |
| MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) | KING & SPALDING LLP | Q3 2026 | Medicare/Medicaid |
| MARC COALITION | KING & SPALDING LLP | Q3 2026 | Medicare/Medicaid |
| GREATER BALTIMORE COMMITTEE | KING & SPALDING LLP | Q3 2026 | Budget/Appropriations |
| EXAMWORKS | KING & SPALDING LLP | Q3 2026 | Health Issues |
| EGENESIS INC. | KING & SPALDING LLP | Q3 2026 | Health Issues |
| COALITION OF INDEPENDENT DISPUTE RESOLUTION ENTITIES, INC. (CIDRE) | KING & SPALDING LLP | Q3 2026 | Health Issues |
| ADVENTIST HEALTHCARE | KING & SPALDING LLP | Q3 2026 | Health Issues |
| ACADIA HEALTHCARE | KING & SPALDING LLP | Q3 2026 | Health Issues |
| SYNCHRON, INC. | KING & SPALDING LLP | Q2 2026 | Medicare/Medicaid, Health Issues |
| KIDNEY TRANSPLANT COLLABORATIVE | KING & SPALDING LLP | Q2 2026 | Health Issues |
| FIRST KEY HOMES | KING & SPALDING LLP | Q1 2026 | Financial Institutions/Investments/Securities |
| KANEKA PHARMA AMERICA, LLC | KING & SPALDING LLP | Q4 2025 | Medicare/Medicaid |
| UNITED CDPAP, INC. | KING & SPALDING LLP | Q1 2025 | Medicare/Medicaid |